Completed PHASE3 INTERVENTIONAL 2-arm NCT01416480

Clinical Trial to Evaluate the Safety and Efficacy of Theobromine Capsule as an Antitussive in Acute Cougher

Therapeutic Confirmatory Clinical Trial to Evaluate the Safety and Efficacy of Theobromine Capsule 300mg as an Antitussive Agent in Acute Cough Patients.

Sponsor: Ahn-Gook Pharmaceuticals Co.,Ltd

Conditions Acute Bronchitis

Interventions Levodropropizine 10mg Theobromine 300mg

Updated 5 times since 2017 Last updated: Aug 12, 2011 Started: May 31, 2010 Primary completion: Feb 28, 2011 Completion: May 31, 2011

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE3 trial investigates Acute Bronchitis and is currently completed. Ahn-Gook Pharmaceuticals Co.,Ltd leads this study, which shows 5 recorded versions since 2010 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE3
Sep 2024 — Sep 2025 [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jan 2017 — Jan 2021 [monthly]

Completed PHASE3

First recorded

May 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Ahn-Gook Pharmaceuticals Co.,Ltd

Data source: Ahn-Gook Pharmaceuticals Co.,Ltd

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Anyang-si, South Korea